Hormonal methods for emergency contraception

被引:0
|
作者
Li, Raymond Hang Wun [1 ,2 ]
Lo, Sue Seen Tsing [1 ,2 ]
Cameron, Sharon Tracey [3 ,4 ]
机构
[1] Univ Hong Kong, Queen Mary Hosp, Sch Clin Med, Dept Obstet & Gynaecol,Pokfulam, 102 Pokfulam Rd, Hong Kong, Peoples R China
[2] Family Planning Assoc Hong Kong, Wan Chai, 10th Floor,130 Hennessy Rd, Hong Kong, Peoples R China
[3] NHS Lothian, Chalmers Sexual Hlth Ctr, 2a Chalmers St, Edinburgh EH3 9ES, Scotland
[4] Univ Edinburgh, Ctr Reprod Hlth, Edinburgh BioQuarter, Edinburgh EH16 4UU, Scotland
关键词
Hormonal emergency contraception; Levonorgestrel; Ulipristal acetate; Mifepristone; Cyclo-oxygenase inhibitors; HUMAN FALLOPIAN-TUBE; ULIPRISTAL ACETATE; IN-VITRO; YUZPE REGIMEN; ONLY PILL; LEVONORGESTREL; MIFEPRISTONE; PREGNANCY; WOMEN; ATTACHMENT;
D O I
10.1016/j.bpobgyn.2024.102550
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
The World Health Organization includes oral emergency contraception (EC) in the list of essential medicines. Ulipristal acetate (UPA) and levonorgestrel (LNG) are the recommended oral methods. UPA has superior efficacy and a comparable side effect profile compared with LNG. Both work by inhibiting or delaying ovulation, so that sperm present in the reproductive tract will have lost their fertilising ability by the time the oocyte is eventually released. Neither LNG nor UPA at the EC doses have significant effects on the endometrium and are unable to prevent implantation. Mifepristone can also be used for EC but its availability is limited to few countries. LNG is less effective in women with a body mass index over 26 kg/m2 or weight over 70 kg. Hormonal contraception can be quickstarted immediately following LNG, or five days following UPA. LNGreleasing intrauterine devices and cyclo-oxygenase inhibitors are promising options for EC to be further studied.
引用
收藏
页数:8
相关论文
共 50 条
  • [31] Mechanism of action of emergency contraception
    Gemzell-Danielsson, Kristina
    CONTRACEPTION, 2010, 82 (05) : 404 - 409
  • [32] Levonorgestrel emergency contraception and bodyweight
    Kardos, Laszlo
    Magyar, Gabriella
    Schvab, Eszter
    Luczai, Eva
    CURRENT MEDICAL RESEARCH AND OPINION, 2019, 35 (07) : 1149 - 1155
  • [33] Hormonal evaluation and midcycle detection of intrauterine glycodelin in women treated with levonorgestrel as in emergency contraception
    Durand, Marta
    Koistinen, Riitta
    Chirinos, Mayel
    Luis Rodriguez, Jose
    Zambrano, Elena
    Seppala, Markku
    Larrea, Fernando
    CONTRACEPTION, 2010, 82 (06) : 526 - 533
  • [34] Emergency Contraception
    Upadhya, Krishna K.
    Breuner, Cora C.
    Alderman, Elizabeth M.
    Grubb, Laura K.
    Hornberger, Laurie L.
    Powers, Makia E.
    Wallace, Stephenie B.
    PEDIATRICS, 2019, 144 (06)
  • [35] Emergency Contraception
    Raymond, Elizabeth G.
    Cleland, Kelly
    NEW ENGLAND JOURNAL OF MEDICINE, 2015, 372 (14) : 1342 - 1348
  • [36] Emergency contraception
    Rabe T.
    Goeckenjan M.
    Gemzell-Danielsson K.
    Der Gynäkologe, 2011, 44 (1): : 10 - 16
  • [37] Emergency contraception
    Prabakar, I.
    Webb, A.
    BRITISH MEDICAL JOURNAL, 2012, 344
  • [38] Effect of body weight and BMI on the efficacy of levonorgestrel emergency contraception
    Kapp, Nathalie
    Abitbol, Jean Louis
    Mathe, Henri
    Scherrer, Bruno
    Guillard, Helene
    Gainer, Erin
    Ullmann, Andre
    CONTRACEPTION, 2015, 91 (02) : 97 - 104
  • [39] Emergency Contraception: Current Methods, Usages and Issues
    Misro, Man M.
    Chaki, Sankar P.
    CURRENT WOMENS HEALTH REVIEWS, 2006, 2 (01) : 33 - 39
  • [40] A review of global access to emergency contraception
    Westley, Elizabeth
    Kapp, Nathalie
    Palermo, Tia
    Bleck, Jennifer
    INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2013, 123 (01) : 4 - 6